ImmuCell

ImmuCell Tax Expense

The Income Tax Expense of ImmuCell (ICCC) as of Nov 16, 2026 is 11,570.00 USD. In the previous year, Income Tax Expense was 10,056.00 USD — a change of 15.06% (higher).

Tax Expense

11,570.00USD

YoY

15.06%

Last updated:

Income Tax Expense of ImmuCell is 2025 11,570.00 USD. Income Tax Expense of ImmuCell was 2024 10,056.00 USD. It decreases by 15.06% higher compared to the previous year.

The ImmuCell Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
462,000.00 USD
Jan 1, 2019
28,000.00 USD
Jan 1, 2020
-10,000.00 USD
Jan 1, 2021
9,165.00 USD
Jan 1, 2022
8,000.00 USD
Jan 1, 2023
4,627.00 USD
Jan 1, 2024
10,056.00 USD
Jan 1, 2025
11,570.00 USD
The ImmuCell Tax Expense history
YEARTax ExpenseYoY
11,570.00USD+15.06%
10,056.00USD+117.33%
4,627.00USD-42.16%
8,000.00USD-12.71%
9,165.00USD-191.65%
-10,000.00USD-135.71%
28,000.00USD-93.94%
462,000.00USD-271.11%
-270,000.00USD-208.05%
249,874.00USD-70.61%
850,309.00USD-1,063.06%
-88,292.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImmuCell stock

Income Tax Expense of ImmuCell is 11,570.00 USD in 2025.

Income Tax Expense of ImmuCell changed from 10,056.00 USD to 11,570.00 USD, representing a 15.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense ImmuCell since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's ImmuCell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ImmuCell

All Key Metrics — ImmuCell